Pharmacokinetic considerations regarding non-viral cancer gene therapy.
about
Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseEngineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsPar-4 as a potential target for cancer therapy.Therapeutic gene editing: delivery and regulatory perspectivesContribution of Epigenetic Modifications to the Decline in Transgene Expression from Plasmid DNA in Mouse Liver.
P2860
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@en
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@nl
type
label
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@en
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@nl
prefLabel
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@en
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@nl
P2093
P2860
P1433
P1476
Pharmacokinetic considerations regarding non-viral cancer gene therapy.
@en
P2093
Makiya Nishikawa
Mitsuru Hashida
Yoshinobu Takakura
P2860
P304
P356
10.1111/J.1349-7006.2008.00774.X
P577
2008-02-19T00:00:00Z